White House kills key drug pricing rule to eliminate hidden rebates | WHAT REALLY HAPPENED

White House kills key drug pricing rule to eliminate hidden rebates

The Trump administration pulled one of its key proposals to lower drug prices by eliminating industry rebates in Medicare — a policy its top health official had touted as one of the most significant changes to curb medicine costs for consumers.

The rule is the second major drug pricing effort to collapse this week, revealing the internal conflicts surrounding the question of how to lower prescription drug costs, which President Trump is eager to campaign on as he courts voters for his reelection.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA